Repair of bone defects using synthetic mimetics of collagenous extracellular matrices

Nature Biotechnology

Volumn 21, Issue 5, 2003, Pages 513-518

  Lutolf, Matthias P ^a,b   Weber, Franz E ^c   Schmoekel, Hugo G ^d   Schense, Jason C ^e   Kohler, Thomas ^a   Müller, Ralph ^a   Hubbell, Jeffrey A ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e Institute Straumann AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CELLS; HYDROGELS; PROTEINS;

EXTRACELLULAR MATRICES;

BIOTECHNOLOGY;

BIOMATERIAL; MACROGOL; MATRIX METALLOPROTEINASE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEFECT; BONE REGENERATION; CONTROLLED STUDY; CRANIOTOMY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYDROGEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RAT; SKIN FIBROBLAST;

ANIMALS; BIOMIMETIC MATERIALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; BONE SUBSTITUTES; COATED MATERIALS, BIOCOMPATIBLE; COLLAGEN; CULTURE TECHNIQUES; EXTRACELLULAR MATRIX; INFUSION PUMPS, IMPLANTABLE; PROSTHESES AND IMPLANTS; RATS; SKULL FRACTURES; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

ANIMALIA; CRANIA;

EID: 0037547104     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt818     Document Type: Article

References (41)

1. Kingsley, D.M. What do BMPs do in mammals: clues from the mouse short-ear mutation. Trends Genet. 10, 16-21 (1994).
2. Wozney, J.M. & Rosen, V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin. Orthop. 346, 26-37 (1998).
3. Schmitt, J.M., Hwang, K., Winn, S.R. & Hollinger, J.O. Bone morphogenetic proteins: an update on basic biology and clinical relevance. J. Orthop. Res. 17, 269-278 (1999).
4. Wozney, J.M. et al. Novel regulators of bone formation: molecular clones and activities. Science 244, 1528-1534 (1988).
5. Fiedlaender, G.E. et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J. Bone Joint Surg. 83A, 151-189 (2001).
6. Li, R.H. & Wozney, J.M. Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol. 19, 255-265 (2001).
7. Brekke, J. & Toth, J. Principles of tissue engineering applied to programmable osteogenesis. J. Biomed. Mat. Res. 43, 365-373 (1998).
8. Uludag, H. et al. Implantation of recombinant being bone morphogenetic proteins with biomaterial carriers, a correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. J. Biomed. Mater. Res. 50, 227-238 (2000).
9. Boyne, P.J. Animal studies of application of rhBMP-2 in maxillofacial reconstruction. Bone 19, 83-92 (1996).
10. Hollinger, J.O. et al. Recombinant human morphogenetic protein-2 and collagen for bone regeneration. J. Biomed. Mater. Res. (Appl. Biomater.) 43, 356-364 (1998).
11. Ellingsworth, L.R., DeLustro, F., Brennan, J.E., Sawamura, S. & McPherson, J. The human immune response to reconstituted bovine collagen. J. Immunol. 136, 8877-8882 (1986).
12. DeLustro, F., Dasch, J., Keefe, J. & Ellingsworth, L. Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivates. Clin. Orthop. 260, 263-279 (1990).
13. Boestman, O. Foreign-body reactions to fracture fixation implants of biodegradable synthetic polymers. J. Bone Joint Surg. 73B, 592-596 (1990).
14. Meikle, M.C. et al. Effect of poly DL-lactide-co-glycolide implants and xenogeneic bone matrix-derived growth factors on calvarial bone repair in the rabbit. Biomaterials 15, 513-521 (1994).
15. Kenley, R. et al. Osseos regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). J. Biomed. Mater. Res. 28, 1139-1147 (1994).
16. Zegzula, D., Buck, D.C., Brekke, J., Wozney, J.M. & Hollinger, J.O. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J. Bone Joint Surg. 79A, 1778-1790 (1997).
17. Ertel, S.I. Evaluation of poly(d-carbonate), a tyrosine-derived degradable polymer, for orthopedic applications. J. Biomed. Mater. Res. 29, 1337-1348 (1995).
18. Anseth, K.S., Sharstri, V.R. & Langer, R. Photopolymerizable degradable polyanhydrides with osteocompatibility. Nat. Biotechnol. 17, 156-159 (1999).
19. Zhu, G., Mallery, S.R. & Schwendeman, S.P. Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide). Nat. Biotechnol. 18, 52-57 (1999).
20. Saito, N. et al. A biodegradable polymer as a cytokine delivery system for inducing bone formation. Nat. Biotechnol. 19, 332-335 (2001).
21. Hubbell, J.A. Bioactive biomaterials. Curr. Opin. Biotechnol. 10, 123-129 (1999).
22. Griffith, L.G. & Naughton, G. Tissue engineering-current challenges and expanding opportunities. Science 295, 1009-1014 (2002).
23. Pratt, A.B. & Hubbell, J.A. Cell-responsive Synthetic Biomaterials Formed In Situ (California Institute of Technology, Pasadena, CA, 2001).
24. Halstenberg, S., Panitch, A., Rizzi, S., Hall, H. & Hubbell, J.A. Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and plasmin-degradable biosynthetic material for tissue repair. Biomacromolecules 3, 710-723 (2002).
25. Gobin, A.S. & West, J.L. Cell migration through defined, synthetic ECM analogs. FASEB 16, 751-753 (2002).
26. Clark, R.A.F. Molecular and Cellular Biology of Wound Repair (Plenum Press, NY, 1996).
27. Woessner, J.F. & Nagase, H. Matrix Metalloproteinases and TIMPs (Oxford Univ. Press, New York, 2000).
28. Sternlicht, M.D. & Werb, Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516 (2001).
29. Vu, T.H. & Werb, Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 14, 2123-2133 (2000).
30. West, J.L. & Hubbell, J.A. Separation of the arterial wall from blood contact using hydrogel barriers reduces intimal thickening after balloon injury in the rat: the roles of medial and luminal factors in arterial healing. Proc. Natl. Acad. Sci. USA. 93, 13188-13193 (1996).
31. Weber, F.E., Eyrich, G., Graetz, K.W., Maly, F.E. & Sailer, H.F. Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly(lactide-co-glycolide) foamspheres. Int. J. Oral Maxillofac. Surg. 31, 60-65 (2002).
32. Ruppert, R., Hoffmann, E. & Sebald, W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur. J. Biochem. 237, 295-302 (1996).
33. Patel, S., Cudney, B. & MacPherson, A. Polymeric precipitants for the crystallinization of macromolecules. Biochem. Biophys. Res. Commun. 207, 819-828 (1995).
34. Uludang, H, et al. rhBMP-collagen sponges as osteoinductive devices: effects of in vitro sponge characteristics and protein pi on in vivo rhBMP pharmacokinetics. Ann. New York Acad. Sci. 875, 369-378 (1999).
35. Elbert, D.L., Pratt, A.B., Lutolf, M.P., Halstenberg, S. & Hubbell, J.A. Protein delivery from materials formed by self-selective conjugate addition reactions. J. Contr. Rel. 76, 11-25 (2001).
36. Weber, F.E. et al. Disulfide bridge conformers of mature BMP are inhibitors for heterotopic ossification. Biochem. and Biophys. Res. Commun. 268, 554-558 (2001).
37. European Agency for the Evaluation of Medicinal Products. European Public Assessment Report: osteogenic protein 1 (Cpmp/0393/01). www.eudra.org/ humandocs/humans/epar/osteogenicprot1/osteogenicprot1.htm (2001).
38. Lutolf, M.P., Tirelli, N., Cerritelli, S., Cavalli, L. & Hubbell, J.A. Systematic modulation of Michael-type reactivity of thiols through the use of charged amino acids. Bioconj. Chem. 12, 1051 (2001).
39. Muller, R. & Ruegsegger, P. Micro-tomographic imaging for the nondestructive evaluation of trabecular bone architecture. Stud. Health Technol. Infor. 40, 61-79 (1997).
40. Odgaard, A. & Gundersen, H.J. Quantification of connectivity in cancellous bone, with special emphasis on 3-D reconstructions. Bone 14, 173-182 (1993).
41. Muller, R., Hildebrand, T. & Ruegsegger, P. Noninvasive bone-biopsy-a new method to analyze and display the 3-dimensional structure of trabecular bone. Phys. Med. Biol. 39, 145-164 (1994).